Dr Peter Charles Nishan, MD | |
1126 N Church St, Suite 300, Greensboro, NC 27401-1000 | |
(336) 547-1700 | |
Not Available |
Full Name | Dr Peter Charles Nishan |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 37 Years |
Location | 1126 N Church St, Greensboro, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407810435 | NPI | - | NPPES |
8735 | Other | NC | PARTNERS MEDICARE |
4613675 | Other | NC | AETNA |
89626681 | Medicaid | NC | |
62681 | Other | NC | BCBS NC |
50419 | Other | NC | MEDCOST |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 9401283 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Moses H Cone Memorial Hospital Operating Corporation | 6204744600 | 496 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.
Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven - but more expensive - therapies, such as antiretroviral (ARV) drugs.
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 8 days ago
Entity Name | The Moses H Cone Memorial Hospital Operating Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356372064 PECOS PAC ID: 6204744600 Enrollment ID: O20031124000541 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.
Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven - but more expensive - therapies, such as antiretroviral (ARV) drugs.
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 8 days ago
Entity Name | Moses Cone Medical Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427095249 PECOS PAC ID: 2769395458 Enrollment ID: O20040128000519 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.
Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven - but more expensive - therapies, such as antiretroviral (ARV) drugs.
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 8 days ago
Entity Name | Moses Cone Affiliated Physicians, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346474103 PECOS PAC ID: 3779635396 Enrollment ID: O20090713000512 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.
Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven - but more expensive - therapies, such as antiretroviral (ARV) drugs.
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 8 days ago
Entity Name | The Moses H Cone Memorial Hospital Operating Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013265909 PECOS PAC ID: 6204744600 Enrollment ID: O20121003000518 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.
Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven - but more expensive - therapies, such as antiretroviral (ARV) drugs.
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Peter Charles Nishan, MD 1200 N Elm St, Greensboro, NC 27401-1004 Ph: (336) 832-7000 | Dr Peter Charles Nishan, MD 1126 N Church St, Suite 300, Greensboro, NC 27401-1000 Ph: (336) 547-1700 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation through a short-form merger.
With soaring obesity rates in the U.S., the American Medical Association has classified obesity as a disease. This major shift in healthcare policy brings much needed medical attention to obese patients.
Global Post examines how "many HIV patients around the world continue to turn to more affordable but far less reliable treatments" instead of proven - but more expensive - therapies, such as antiretroviral (ARV) drugs.
Pasta and other foods rich in carbohydrates have long been removed from weight loss diets. According to a new study from researchers at the University of Toronto, pasta could actually be a valid component of a dieting routine.moderate amounts of pasta in diet leads to weight loss
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.
› Verified 8 days ago
Dr. Olugbemiga Ebenezer Jegede, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E Wendover Ave, Greensboro, NC 27401 Phone: 336-832-4444 Fax: 336-832-4445 | |
Yan Feng, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Dr. Gary Bradley Sherrill, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Edwin Aziegbe Avbuere, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3231 Yanceyville Street, Greensboro, NC 27405 Phone: 336-358-1528 Fax: 336-358-1582 | |
Dr. Jay Krishnavadan Patel, MB.CHB Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 309 New St, Carolina Kidney Associates, Greensboro, NC 27405 Phone: 336-379-9708 Fax: 336-553-2085 | |
Gayatri A Acharya, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Northline Ave Ste 250, Greensboro, NC 27408 Phone: 336-273-7900 | |
Murali Ramaswamy, MD FAAFP Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 520 N Elam Ave, Greensboro, NC 27403 Phone: 336-547-1801 Fax: 336-547-1828 |